XML 39 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Teijin Agreement - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended
Aug. 31, 2016
Mar. 31, 2017
Dec. 31, 2016
Revenue Recognition Milestone Method [Line Items]      
Upfront payment from collaboration partner   $ 40,000,000 $ 40,000,000
Teijin Limited [Member] | License and Supply Agreement [Member]      
Revenue Recognition Milestone Method [Line Items]      
Potential to receive development milestone $ 35,000,000    
Percentage of running royalty and transfer pricing receivable range, high 20.00%    
Percentage of running royalty and transfer pricing receivable range, mid 30.00%    
Agreement expiration terms   The Agreement continues until the earlier of (i) twelve years after the first commercial sale of a licensed product in Japan, or (ii) the expiration of certain Versartis patents, unless terminated earlier by mutual agreement of the parties. The initial term of the Agreement is subject to automatic extension for three three-year terms, unless otherwise mutually agreed. The Agreement may be earlier terminated by either party for the other party’s uncured material breach or insolvency. In addition, Teijin may terminate the Agreement without cause upon six months’ advance notice prior to the sale of a licensed product, and upon twelve months’ notice thereafter.  
Agreement expiration period after commercialization   12 years  
Agreement automatic extension term   3 years  
Upfront payment from collaboration partner   $ 40,000,000  
Teijin Limited [Member] | License and Supply Agreement [Member] | Upfront Payment Arrangement [Member]      
Revenue Recognition Milestone Method [Line Items]      
Payments received under license and supply agreement $ 40,000,000    
Maximum [Member] | License and Supply Agreement [Member]      
Revenue Recognition Milestone Method [Line Items]      
Costs associated with additional trials 5,000,000    
Maximum [Member] | Teijin Limited [Member] | License and Supply Agreement [Member]      
Revenue Recognition Milestone Method [Line Items]      
Potential to receive regulatory milestone 55,000,000    
Potential to receive sales milestone $ 35,000,000